Clinic of Nephrology, Faculty of Medicine, University of Thessaly

Company Profile

In its current form the Clinic of Nephrology consists of the following departments:

• Nephrology Department, with 13 beds for hospitalisation of patients with nephrologjcal disorders and kidney transplantation. There is also a two beds day clinic, which is located in the Hemodialysis Unit. 
• Nephrological Policlinic, which functions daily for patients with nephrologjcal disorders and kidney transplantation.
• Hemodialysis Unit, with 11 places for chronic dialysis and 44 patients with ESRD. The Unit is equipped blood gases analyst, photomicroscope, and all essential instruments.
• Peritoneal Dialysis Unit, with 28 patients with ESRD. The Unit is located in the Nephrology Ward, including an one bed room for the education and the acute treatment of patients.
• Therapeutic Plasmapheresis Unit, unique in the region. 
• Nephrological research laboratory

R&D activities 

• Site for R&D: Nephrological research laboratory and various clinical wards
• Studies on the systemic influence of renal disease and therapies. Neuromuscular, metabolic and endocrine disorders in CKD. Influence of exercise training and other pharmacological and non-pharmacological treatment methods. 
• Clinical trials phase 3, 4.
• In vitro studies on interactions of metabolism (aerobic glycolysis, Krebs cycle) and prolipheration of lymphocytes (T-cells, B-cells, investigating immunity) and of renal tubular cells (investigating ishemia). Physiology of mesothelial cells.
• Genetics of multifactorial disorders in Nephrology. Diabetic nephropathy, hypertension, CKD progression.

Target Partners & Collaborations

Our target partners come from the following groups of companies and activities:

• Pharmaceutical companies
• Contract Research Organisations
• Genetics laboratories
• Nephrological centers

Technologies / Services offered or sought

Studies on the systemic influence of renal disease and therapies. Neuromuscular, metabolic and endocrine disorders in CKD. Influence of exercise training and other pharmacological and non-pharmacological treatment methods.

Future plan: Expand the studies with Regional and National cooperations.

Clinical trials phase 3, 4.

Future plan: In cooperation with industry pharmacokinetics in CKD, bioequivalence.

In vitro studies on interactions of metabolism (aerobic glycolysis, Krebs cycle) and prolipheration of lymphocytes (T-cells, B-cells, investigating immunity) and of renal tubular cells (investigating ishemia). Physiology of mesothelial cells.

Future plan: In vivo experimental studies on nephroimmunology.

Genetics of multifactorial disorders in Nephrology. Diabetic nephropathy, hypertension, CKD progression.